• January 15, 2008

Caraco Pharmaceutical Laboratories of Detroit has been grated final FDA approval for its Cetirizine Hydrochloride Chewable Tablets.

Cetirizine HCl Chewable, which will be marketed as two separate OTC products in two strengths, 5 mg and 10 mg, is an antihistamine drug, which is used to treat allergies, hives, and other allergic inflammatory conditions.

These new products are bioequivalent to Children's Zyrtec chewable tablets for allergy relief and Children's Zyrtec for hives relief, registered trademarks of Johnson & Johnson.

--Nina M. Lentini